UC Davis researchers recently announced the development of a new neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential.

KVMR's Sherrie Cunningham spoke to Dr. David E. Olson, director of the Institute for Psychedelics and Neurotherapeutics at UC Davis to learn more.